VITA — Vitaminka AD Prilep Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapNeutral

Annual income statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	—	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,824	3,812	3,247	3,501	4,611
Cost of Revenue
Gross Profit	795	865	1,081	1,173	1,178
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,704	3,700	3,069	3,328	4,551
Operating Profit	120	112	178	173	59.8
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	83.2	75.3	109	100	16.8
Provision for Income Taxes
Net Income After Taxes	76.2	69.8	99.3	90	9.93
Net Income Before Extraordinary Items
Net Income	76.2	69.8	99.3	90	9.93
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	76.2	69.8	99.3	90	9.93
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	953	939	1,267	1,108	134
Dividends per Share